Comment l’eau et le vent créent-ils des paysages à couper le souffle
La diversité et la beauté de nos paysages terrestres doivent beaucoup à un phénomène essentiel en géologie : l’érosion. Menée ...
Gamesider on MSN4d
Dragon Ball Z : voici les vrais noms de C-17 et C-18, vous allez être surpris
Si l'histoire de C-17 et C-18 a été assez détaillée dans le manga, Akira Toriyama avait révélé dans un tome spécial en 2014 ...
Techno-Science.net17d
Virus métamorphique - Définition
La caractéristique principale d'un virus métamorphique est sa capacité à modifier sa structure interne ainsi que les instructions qui le composent. Le métamorphisme est un mécanisme de défense utilisé ...
FierceBiotech21d
Roche bets up to $1B to expand Dyno gene therapy delivery pact
After forming a gene therapy partnership with Dyno Therapeutics in 2020, Roche is back for more. In a new deal potentially worth more than $1 billion, Roche is paying Dyno $50 million upfront to ...
BioSpace21d
Roche Inks Potential $1B Gene Therapy Deal With Dyno, Eyes Neurological Diseases
With an upfront payment of $50 million from Roche, the partnership will leverage Dyno Therapeutics’ in vivo gene therapy delivery technology, which synthesizes virus capsids with better functionality ...
Reuters21d
Roche comes out against allowing takeover of drug manufacturer Catalent
Roche CEO: not good to limit competition in this space Roche says not itself, but others affected by Catalent deal Swiss drugmaker joins US peer Lilly in voicing opposition Eli Lilly and advocacy ...
FiercePharma21d
Roche CEO says Novo's Catalent buyout 'could be a problem' for smaller drugmakers
Speaking to the press Wednesday, Roche’s chief executive Thomas Schinecker critiqued the proposed transaction, arguing that it could hamper the ability of smaller biopharma players to lock down ...
Seeking Alpha21d
Roche reaffirms 2024 outlook after Q3 beat
Swiss Pharmaceutical giant Roche Holding (OTCQX:RHHBY) (OTCQX:RHHBF) on Wednesday reaffirmed its full-year sales and earnings outlook after the company’s third-quarter sales results exceeded ...
FiercePharma22d
Roche's Vabysmo will rise above Eylea biosim threat, exec says, as DMD gene therapy Elevidys delivers sales surprise
Roche doesn’t think so. “I think we don’t see anything that should be slowing Vabysmo momentum down,” Teresa Graham, CEO of Roche Pharmaceuticals, said during a press conference Wednesday ...
Wall Street Journal22d
Roche Confirms Profit Forecast as Sales Beat Estimates
Roche ROG-1.53%decrease; red down pointing triangle confirmed its profit outlook for the year after its eye drug Vabysmo, multiple-sclerosis treatment Ocrevus and hemophilia injection Hemlibra ...
Reuters22d
Roche CEO says more people have mpox in Europe than has been reported
FRANKFURT, Oct 23 (Reuters) - The CEO of Roche (ROG.S), opens new tab said he has been informed that more cases of mpox infection have occurred in Europe than previously reported and that the ...
BioSpace23d
Roche Trims Another Alzheimer’s Prospect, Ending UCB Collabortion
Roche drops a third Alzheimer’s candidate this year, terminating a partnership with UCB just four years after agreeing to work together on new treatments for the neurological disease. Roche has cut ...